Om Prakash Yadava,Vivek Rao
Om Prakash Yadava
Dr. O.P. Yadava, CEO and Chief Cardiac Surgeon, National Heart Institute, New Delhi, India, and Editor-in-Chief, Indian Journal of Thoracic and Cardiovascular Surgery, in conversation with Dr. Vivek Rao, Chief of Cardiovascular Surgery, Pet...
Om Prakash Yadava
Om Prakash Yadava
Dr. O.P. Yadava, CEO and Chief Cardiac Surgeon, National Heart Institute, New Delhi, India, and Editor-in-Chief, Indian Journal of Thoracic and Cardiovascular Surgery, in a conversation with Dr. Catherine Dushyant Sudarshan, discusses the s...
Vishal Rastogi,Aparna Jaswal
Vishal Rastogi
Advanced Heart Failure is one of the leading causes of death and hospitalization worldwide. Its incidence is increasing steadily in India as well. Despite a huge need, not many cardiologists take heart failure as a career option. The presen...
Transplantation for chemotherapy-induced cardiomyopathy-case series and review of current practice [0.03%]
化疗引起的心肌病的移植治疗-病例分析与当前治疗方法综述
Komarakshi Rajagopalan Balakrishnan,Kemundel Genny Suresh Rao,Ganapathy Subramaniam et al.
Komarakshi Rajagopalan Balakrishnan et al.
Multimodality therapies have improved the survival after tumors like Ewing's sarcoma and breast cancer. However, cardiotoxicity following chemotherapy remains an important concern. We report a case series of four patients who presented to o...
Heterotopic heart transplant: relevance as Bio-VAD in emerging economies [0.03%]
异位心脏移植：在新兴经济体中的作为生物VAD的相关性
Prashant Vaijyanath
Prashant Vaijyanath
Despite the introduction of mechanical circulatory assist systems in India two decades ago, there has not been their wide usage due to two main reasons: (1) economic-financial unaffordability and (2) lack of social support. There have been ...
An ambulatory counterpulsation system-a potential option for extended mechanical support [0.03%]
行走反向增压系统--扩展机械支持的潜能选择
Trever Symalla,Valluvan Jeevanandam
Trever Symalla
As the incidence of heart failure increases, an organ shortage for cardiac transplant worsens. There has been development of both short and long-term mechanical circulatory devices for this population, each with unique advantages and differ...
Trever Symalla,Valluvan Jeevanandam
Trever Symalla
The increasing incidence of advanced heart failure and severe donor organ shortage for cardiac transplant has led to the development of implantable left ventricular assist devices (LVAD) for long-term mechanical circulatory support. There h...
Sam Emmanuel,Jared Engelman,Christopher Simon Hayward
Sam Emmanuel
Background: Ventricular assist devices (VADs) have provided a temporising solution to many individuals with refractory heart failure (HF) while awaiting a suitable donor for heart transplantation which remains the gold st...
Cumaraswamy Sivathasan
Cumaraswamy Sivathasan
The concept of a mechanical device to support failing hearts arose after the introduction of the heart lung bypass machine pioneered by Gibbon. The initial devices were the pulsatile paracorporeal and total artificial heart (TAH), driven by...
DCD donations and outcomes of heart transplantation: the Australian experience [0.03%]
心脏移植的DCD捐献及结果：澳大利亚的经验
Kumud Dhital,Prakash Ludhani,Sarah Scheuer et al.
Kumud Dhital et al.
Purpose: There is increasing clinical utilization of hearts from the donation after circulatory death (DCD) pathway with the aim of expanding the donor pool and mitigating the ever-present discrepancy between the inadequa...